Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2021-10-28 M&A Activity
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Vita 34 AG: Exchange Offer PBKM - 95% Minimum Acceptance Rate Exceeded
M&A Activity Classification · 98% confidence The document is an 'Ad-hoc' announcement dated October 28, 2021, disclosing that Vita 34 AG's voluntary public exchange offer for PBKM shares has exceeded the 95% minimum acceptance rate. This clearly relates to a merger, acquisition, or takeover activity ('Exchange Offer PBKM'). The filing explicitly mentions 'Mergers & Acquisitions' as a keyword and discusses the fulfillment of a closing condition for a share exchange, which falls under the definition of M&A Activity. Therefore, the appropriate classification is TAR (M&A Activity). The document is a formal announcement of a transaction milestone, not a full report or a general regulatory filing.
2021-10-28 English
Vita 34 AG extends the acceptance period under PBKM exchange offer
M&A Activity Classification · 98% confidence The document is a news release dated October 11, 2021, originating from Vita 34 AG, disseminated via DGAP. The core content announces an extension of the acceptance period for a voluntary exchange offer concerning shares in PBKM. This type of announcement, which details corporate actions related to securities exchange, takeover bids, or significant corporate transactions, falls under the scope of M&A Activity (TAR). Although it mentions regulatory bodies (BaFin, KNF), the primary subject is the extension of a tender/exchange offer, which is a key component of M&A activity. It is not a full report (10-K, IR), a dividend notice (DIV), or a management change (MANG). Since it is a specific corporate action announcement related to an offer for another company's shares, TAR is the most appropriate classification over the general fallback RNS.
2021-10-11 English
Vita 34 AG launches voluntary public exchange offer for PBKM shares
M&A Activity Classification · 99% confidence The document is a news release titled "Vita 34 AG launches voluntary public exchange offer for PBKM shares." It details the terms of an exchange offer (a form of M&A activity) where Vita 34 is offering its shares in exchange for shares in PBKM. This clearly falls under the category of corporate actions related to mergers, acquisitions, or takeovers. The most appropriate classification among the provided options is 'M&A Activity' (TAR). It is not a full financial report (10-K, IR), an earnings release (ER), or just a simple dividend notice (DIV). Since it is a detailed announcement about a transaction, it is not a generic Regulatory Filing (RNS) or a Report Publication Announcement (RPA).
2021-09-20 English
Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year
Earnings Release Classification · 100% confidence The document is a news release dated August 31, 2021, titled "Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year." It explicitly mentions "Key word(s): Half Year Results" and provides detailed financial figures for Q2 2021 and H1 2021 (First Half of the Year). This content structure—a summary of financial performance for a period shorter than a full year, released mid-year—is characteristic of an Interim/Quarterly Report (IR). It is not the full Annual Report (10-K), nor is it merely an announcement of a report (RPA), as it contains the core financial data and management commentary. It is more comprehensive than a simple Earnings Release (ER) which usually only contains highlights. H1 2021
2021-08-31 English
Half-yearly financial report 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and covers the period from January to June 2021. It contains detailed financial statements, including the 'Condensed Consolidated Income Statement', 'Condensed Consolidated Balance Sheet', and 'Condensed Consolidated Cash Flow Statement', as well as a 'Management Report' and 'Responsibility Statement'. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2021
2021-08-31 German
Report Publication Announcement 2021
Report Publication Announcement Classification · 100% confidence The document is titled "Vita 34 AG: Preliminary announcement of the publication of financial reports..." and explicitly states that the company "hereby announces that the following financial reports shall be disclosed," providing future disclosure dates (August 31, 2021) and links to where the reports will be available. This structure—announcing the future release of a report rather than containing the report itself—fits the definition of a Report Publication Announcement (RPA). The document is very short (1785 characters), reinforcing the 'MENU VS MEAL' rule.
2021-08-24 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.